Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Teva
Julphar
Baxter
Mallinckrodt
Healthtrust
Cantor Fitzgerald
US Army
Farmers Insurance

Generated: April 23, 2018

DrugPatentWatch Database Preview

METARAMINOL BITARTRATE Drug Profile

« Back to Dashboard

Drug patent expirations by year for METARAMINOL BITARTRATE
Medical Subject Heading (MeSH) Categories for METARAMINOL BITARTRATE
Synonyms for METARAMINOL BITARTRATE
(-)-alpha-(1-Aminoethyl)-3-hydroxybenzenemethanol
(-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate
(-)-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol tartrate (1:1) (salt)
(-)-Metaraminol bitartrate
(1R,2S)-2-amino-1-(3-hydroxyphenyl)propan-1-ol hydrogen (2R,3R)-tartrate
1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol bitartrate
1-alpha-(1-Aminoethyl)-m-hydroxybenzyl alcohol hydrogen d-tartrate
17171-57-2
2539AH
3-(2-amino-1-hydroxypropyl)phenol 2,3-dihydroxybutanedioate(1:1)
3-(2-amino-1-hydroxypropyl)phenol; (2R,3R)-2,3-dihydroxybutanedioic acid
3-(2-amino-1-hydroxypropyl)phenol; (2S,3S)-2,3-dihydroxybutanedioic acid
3-(2-amino-1-hydroxypropyl)phenol; 2,3-dihydroxybutanedioic acid
3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol; (2R,3R)-2,3-dihydroxybutanedioic acid
3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol; 2,3-dihydroxybutanedioic acid
3-[(1R,2S)-2-amino-1-hydroxypropyl]phenol;(2R,3R)-2,3-dihydroxybutanedioic acid
3-[(1R,2S)-2-azanyl-1-oxidanyl-propyl]phenol; 2,3-bis(oxidanyl)butanedioic acid
33402-03-8
36699-41-9
402M038
54-49-9 (Parent)
962-81-2
962-82-3
A821761
AC1L1VSO
AC1L4VEP
AC1L9B4D
AC1NWAWA
AC1O4WHG
AKOS015915053
AKOS030539470
API0003261
Aramine (sympathominetic)
Araminum
Araminum ampullen
Benzenemethanol, alpha-((1S)-1-aminoethyl)-3-hydroxy-, (alphaR)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
Benzenemethanol, alpha-(1-aminoethyl)-3-hydroxy-, (-)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
Benzenemethanol, alpha-(1-aminoethyl)-3-hydroxy-, (R-(R*,S*))-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
Benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)-, (-)-tartrate (1:1)
Benzyl alcohol, alpha-(1-aminoethyl)-m-hydroxy-, (-)-, tartrate (1:1) (salt)
BENZYL ALCOHOL, alpha-(1-AMINOETHYL)-m-HYDROXY-, TARTRATE (1:1), D-(-)-
BPBio1_000169
BSPBio_000153
BSPBio_003506
C9H13NO2.C4H6O6
CCG-213141
CCG-39320
CHEMBL1480611
CHEMBL2062262
CHEMBL3184244
CS-4715
CTK5H8654
D01019
DivK1c_000793
DSSTox_CID_25580
DSSTox_GSID_45580
DSSTox_RID_80976
DTXSID1045580
EINECS 251-502-3
EX-A1348
HMS1922M17
HMS2093A03
HMS502H15
HY-B1116
I14-7474
IDI1_000793
IMS metaraminol bitartrat ampullen
J-019180
KBio1_000793
KBio2_002093
KBio2_004661
KBio2_007229
KBio3_003011
KBioGR_001573
KBioSS_002093
KS-1368
l-1-(m-Hydroxyphenyl)-2-amino-1-propanol-d-hydrogen tartrate
l-Metraminol bitartrate
L(+)-TARTARIC ACID; METARAMINOL
Levicor
Levicor ampullen
LS-42655
METARADRINE BITARTRATE
Metaradrine tartrate
Metaramin
Metaraminol (+)-bitartrate salt
Metaraminol (R,R)-hydrogentartrat
Metaraminol (tartrate)
Metaraminol Bitartrate (1:1)
Metaraminol bitartrate (hydrogen l-tartrate)
Metaraminol bitartrate (JAN/USP)
Metaraminol bitartrate [USAN:JAN]
Metaraminol bitartrate [USP:JAN]
Metaraminol bitartrate salt
Metaraminol bitartrate, United States Pharmacopeia (USP) Reference Standard
Metaraminol hydrogen (+)-tartrate
Metaraminol Tartrate
Metaraminol tartrate (1:1)
MFCD00238763
MLS004712030
MolPort-003-666-469
MolPort-035-395-286
NCGC00095031-01
NCGC00095031-02
NCGC00178024-05
NINDS_000793
NSC-169915
NSC-758425
NSC169915
NSC758425
OR067112
Pharmakon1600-01503251
Pressonex bitartrate
Prestwick_592
Prestwick0_000197
Prestwick1_000197
Prestwick2_000197
Prestwick3_000197
SBB068569
SCHEMBL11098329
SCHEMBL3671997
SCHEMBL40982
SCHEMBL5564262
SMR003475005
SPBio_001384
SPBio_002074
Spectrum_001613
SPECTRUM1503251
Spectrum2_001542
Spectrum3_001913
Spectrum4_000877
Spectrum5_001241
SR-01000939828
SR-01000939828-2
Tox21_110778
Tox21_110778_1
UNII-ZC4202M9P3
ZC4202M9P3

US Patents and Regulatory Information for METARAMINOL BITARTRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm METARAMINOL BITARTRATE metaraminol bitartrate INJECTABLE;INJECTION 080431-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Gd Searle Llc METARAMINOL BITARTRATE metaraminol bitartrate INJECTABLE;INJECTION 086418-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Elkins Sinn METARAMINOL BITARTRATE metaraminol bitartrate INJECTABLE;INJECTION 083363-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fresenius Kabi Usa METARAMINOL BITARTRATE metaraminol bitartrate INJECTABLE;INJECTION 080722-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Farmers Insurance
Moodys
Teva
Fuji
QuintilesIMS
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.